Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
grade D 63.69 -2.15% -1.40
NVO closed down 2.15 percent on Thursday, August 6, 2020, on 1.55 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical NVO trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness -2.15%
MACD Bearish Centerline Cross Bearish -1.45%
Stochastic Reached Oversold Weakness -1.45%
Gapped Down Weakness -1.45%
Lower Bollinger Band Touch Weakness -1.45%
Oversold Stochastic Weakness -1.45%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Obesity Hormones Insulin Peptide Hormones Biopharmaceuticals Glucagon Like Peptide 1 Diabetes Care Anti Diabetic Drugs Hormone Therapy

Is NVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 68.96
52 Week Low 48.6
Average Volume 1,227,141
200-Day Moving Average 61.01
50-Day Moving Average 65.97
20-Day Moving Average 66.32
10-Day Moving Average 65.91
Average True Range 1.20
ADX 13.15
+DI 21.07
-DI 36.42
Chandelier Exit (Long, 3 ATRs ) 65.36
Chandelier Exit (Short, 3 ATRs ) 66.87
Upper Bollinger Band 68.92
Lower Bollinger Band 63.72
Percent B (%b) -0.01
BandWidth 7.84
MACD Line -0.29
MACD Signal Line 0.10
MACD Histogram -0.3922
Fundamentals Value
Market Cap 157.96 Billion
Num Shares 2.48 Billion
EPS 2.49
Price-to-Earnings (P/E) Ratio 25.58
Price-to-Sales 6.57
Price-to-Book 15.49
PEG Ratio 2.42
Dividend 0.95
Dividend Yield 1.49%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 65.13
Resistance 3 (R3) 65.15 64.69 64.89
Resistance 2 (R2) 64.69 64.32 64.68 64.81
Resistance 1 (R1) 64.19 64.10 63.96 64.17 64.73
Pivot Point 63.73 63.73 63.62 63.72 63.73
Support 1 (S1) 63.23 63.36 63.00 63.21 62.65
Support 2 (S2) 62.77 63.14 62.76 62.57
Support 3 (S3) 62.27 62.77 62.49
Support 4 (S4) 62.25